XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 93 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q1 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $586 | +78.7% | 315,487 | +151.5% | 0.00% | – |
| Q2 2023 | $328 | -30.4% | 125,438 | -56.7% | 0.00% | -100.0% |
| Q1 2023 | $471 | +2.4% | 289,450 | -16.4% | 0.00% | 0.0% |
| Q4 2022 | $460 | -99.9% | 346,382 | -15.0% | 0.00% | 0.0% |
| Q3 2022 | $635,000 | -21.3% | 407,609 | -22.3% | 0.00% | 0.0% |
| Q2 2022 | $807,000 | -86.6% | 524,294 | -77.7% | 0.00% | -85.7% |
| Q1 2022 | $6,022,000 | -17.1% | 2,352,599 | -5.2% | 0.01% | -12.5% |
| Q4 2021 | $7,268,000 | – | 2,480,675 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,039,028 | $15,460,000 | 19.22% |
| Stonepine Capital Management, LLC | 7,924,056 | $20,286,000 | 8.41% |
| ARMISTICE CAPITAL, LLC | 7,464,993 | $19,110,000 | 0.37% |
| NEA Management Company, LLC | 3,246,785 | $8,312,000 | 0.24% |
| Alpine Global Management, LLC | 633,040 | $1,620,000 | 0.20% |
| DELTEC ASSET MANAGEMENT LLC | 248,000 | $635,000 | 0.11% |
| Redmile Group, LLC | 1,046,587 | $2,679,000 | 0.08% |
| CTC Capital Management, LLC | 11,800 | $30,000 | 0.08% |
| TUDOR INVESTMENT CORP ET AL | 961,192 | $2,461,000 | 0.06% |
| Yakira Capital Management, Inc. | 117,076 | $300,000 | 0.04% |